Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,353 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Gas costs are squeezing budgets as consumers cut back on dining out. Retailers feel the pull as higher fuel bills tak...
Investors are exploring whether steady dividend income can fund a decade-long giving plan without depleting savings. ...
A baby boomer dad who spent years cleaning overnight helped his five children attend a private college tuition-free, ...
A new consumer-ready humanoid named Neo hits preorder with a $20,000 price tag, promising to handle simple chores at ...
Visa sits at the center of a rising wave of short bets, even as it preserves a cash-generating moat. The latest data ...
PennantPark pays an about 20% yield through an $0.08 monthly payout, but a spillover reserve backs part of the divide...
UN World Food Programme chief Cindy McCain warns that hunger is becoming a corporate risk as food costs climb and sup...
The musician sheryl crow selling a 2.2-acre slice from her Nashville estate for $1.8 million highlights growing liqui...
The 2026 COLA rose 2.8%, but higher living costs outpaced the gain, squeezing retirees as inflation remains stubbornl...
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Three international dividend ETFs are delivering notably higher yields than SCHD in mid-2026, driven by cheaper overs...